Alex Dav Inv. Share Discussion Threads

[asmodeus] 31/3/2014 08:22

This is a charity that needs your support. The Directors probably have school, or "Uni", and holiday bills to pay, and will need your money to pay them. Note the word your.

[harrysbank] 31/3/2014 08:14

And the lucky winner of all the fin advantages this shell brings is ...
Tiziana Pharma

Ground breaking metastasis (when cancer spreads) drug which treats the nasty gene Bcl-3, research by team out of Cardiff Uni showed a complete stop of the effect in early trials on mice

300:1 share consolidations too and placement raising £2m

hxxp://www.sciencedaily.com/releases/2014/01/140125224927.htm

Game on

[kennyruss] 31/3/2014 08:14

interesting!!

[asmodeus] 31/3/2014 08:10

Proposed acquisition of Tiziana Pharma Limited
Placing of 16,666,667 New Ordinary Shares at a price of £0.12 per share
Change of name to Tiziana Life Sciences PLC
300:1 share consolidation
Notice of general meeting

Alexander David Investments plc (AIM: ADI), announces that a circular, comprising an admission document ("Admission Document") and a notice of general meeting, has been posted to shareholders. Defined terms in this announcement have the same meaning as those in the Admission Document.

To view this announcement in full, please click on the link below and see 'Latest News':

[share_shark] 31/3/2014 08:06

nder David Investments PLC Publication Of Admission Document & Lifting Of Suspension






Proposed acquisition of Tiziana Pharma Limited

TIDMADI

31 March 2014

Alexander David Investments plc

(to be renamed Tiziana Life Sciences PLC)

(the "Company")

PUBLICATION OF ADMISSION DOCUMENT & LIFTING OF SUSPENSION

Proposed acquisition of Tiziana Pharma Limited

Placing of 16,666,667 New Ordinary Shares at a price of GBP0.12 per
share

Change of name to Tiziana Life Sciences PLC

300:1 share consolidation

Notice of general meeting

Alexander David Investments plc (AIM: ADI), announces that a circular,
comprising an admission document ("Admission Document") and a notice of
general meeting, has been posted to shareholders. Defined terms in this
announcement have the same meaning as those in the Admission Document.

A copy of the circular may be downloaded from the Company's website at
www.ad-investments.com.

Following publication of the Admission Document, the temporary
suspension to trading in the Company's shares will be lifted with effect
from 7:30 a.m. today and trading in the Company's shares will resume at
8:00 a.m.

Summary

The Company is pleased to announce that it has conditionally agreed
terms in respect of the proposed acquisition of the entire issued share
capital of Tiziana Pharma, which is a development stage biotechnology
company. The consideration of GBP7.50 million is to be satisfied by the
issue of New Ordinary Shares at a price of GBP0.12 per share, which
values the Existing Share Capital at GBP0.24 million, representing a 53
per cent. discount to the Company's share price on 19 December 2013, the
date on which trading was temporarily suspended. The Company has raised
GBP2.00 million (before expenses) by means of the Placing which will be
used to develop the intellectual property rights in Tiziana Pharma and
for general working capital purposes.

The Acquisition, if completed, is of sufficient size to constitute a
reverse takeover under the AIM Rules and therefore is subject to the
approval of shareholders at a General Meeting.

Tiziana Pharma


-- Tiziana Pharma was formed in November 2013 as a vehicle to acquire and
exploit certain intellectual property in biotechnology.

-- Tiziana Pharma's mission is to discover and develop novel molecules that
impact human disease in the area of oncology, with a particular focus on
metastatic cancers.

-- The first of Tiziana Pharma's programmes seeks to develop a drug for
application in the therapeutic area of metastatic breast cancer.


-- The intellectual property was developed by Dr Andrea Brancale (senior
research academic), Dr Richard Clarkson (senior research academic) and Dr
Andrew Westwell (reader in Medicinal Chemistry), all of whom are from
Cardiff University.


-- The intellectual property focuses on targeting the product of the B-cell
Lymphoma 3 gene (Bcl-3), the inhibition of which affects a cancer cell's
ability to migrate.


Gabriele Cerrone, Executive Chairman of Tiziana Pharma, said: "The
spread of tumors around the body, termed metastasis, accounts for
approximately 90 per cent. of all cancer-related deaths. The board of
Tiziana Pharma believe that there is an unmet need in the breast cancer
field for increased efficacy over existing therapies, and that there is
therefore a ready market for a novel treatment that is able to improve
survival in patients diagnosed with cancer who might progress to
metastatic disease. Tiziana Pharma's research team is attributed with
the discovery that Bcl-3 has a prominent role in the metastasis of
mammary cancers. Furthermore, Tiziana Pharma's lead compound has shown
significant anti-metastatic activity in preclinical trials designed to
demonstrate the inhibition of disease progression and further spread of
metastatic lesions. Aided by the enlarged group's strengthened balance
sheet and access to public markets via an AIM listing, we look forward
to building on our success to date by progressing this promising
candidate into phase I clinical trials, and creating shareholder value
growth in the medium and longer term."

Enquiries

[smcl] 24/3/2014 11:27

alby220

I couldn't agree more. But hindsight is a great thing! All the best.

sm

[alby220] 24/3/2014 11:05

The Fiasco trundles on regardless, Imo this is heading for a train wreck scenario. I wish I never set eyes on RGT and consequently got stuck with this !

[stenick] 21/3/2014 19:21

An update will come!

[alby220] 13/3/2014 14:32

A Update ! I don't hold out much hope there then . Like me I bet you wished you never set eyes on these two cursed company's.
Had great hope for RGT years ago that soon went away. And this one imo hopeless in the extreme.

[genises] 13/3/2014 13:55

2 months alby
Results are due and hopefully an update.
Never did receive the letter what a waste of an RNS.

[alby220] 12/3/2014 17:02

How long left before they are forced by aim to delist?

[doorway] 03/3/2014 01:39

what mug punters did they get to invest in adi in the first place....bucket shop scam comes to mind here....
maybe ther need to be investigated

[genises] 25/2/2014 23:30

must have forgotten to pay the postage on the three thousand shareholders hence still no delivery.

[alby220] 25/2/2014 09:35

Letter is now available on "this Company's website to be downloaded .
Were in the money ! NOT.

[alby220] 25/2/2014 09:30

Has anyone found out what this "Letter" was ??
It is becoming clearer to me that this "Crock of Gold !"?? Has indeed vanished for us "Suckers"

[doorway] 25/2/2014 01:33

makes me laugh if carlsberg did aim shares this it it

[rovi67] 24/2/2014 13:40

* . * = reform

[alby220] 22/2/2014 20:20

Sorry Doorway, *.* School upbringing / completely wasted on me. Therefore I find it difficult to Curse.

[doorway] 22/2/2014 17:16

still too polite

[alby220] 21/2/2014 14:35

Agreed! SS they are clearly a total bunch of twerps!!

[share_shark] 21/2/2014 14:15

"cyber space" alby ?. That is too polite a word and excuse for it wouldnt you say ?.

[alby220] 21/2/2014 12:05

Letter still stuck in cyber space What a bunch of incompetents.

[genises] 21/2/2014 10:02

nothing changes.
Properly after more money after spending/investing and losing the last million.
Some one needs to pay their wages.

[alby220] 21/2/2014 09:27

Sims right they have completely messed it up yet again.

[sims6] 20/2/2014 22:19

there's a letter the shareholders out. Can't see it but there's a copy on there website, it says

but you can't see it there either haha. This whole company is just one big mistake. They can't even get this right LMAO